Light Mode
$2.84 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.84, $0.06 below the day’s high of $2.90
-0.32 (-10.13%) / 6M
Momentum, market sentiment, and recent alerts
QTRX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -51.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.